Skip to main content
Log in

Antiviral prophylaxis cost saving for preventing perinatal HBV

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2010 US dollars

Reference

  • Fan L, et al. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology : 28 Oct 2015. Available from: URL: http://doi.org/10.1002/hep.28310

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antiviral prophylaxis cost saving for preventing perinatal HBV. PharmacoEcon Outcomes News 740, 10 (2015). https://doi.org/10.1007/s40274-015-2565-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2565-0

Navigation